Health BehaviorNCT05984966
Supported Employment COVID-19 Rapid Testing for PWID
A study testing Supported Employment in people with Health Behavior, run by University of Oregon at 1 site in United States.
Trial summary
This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The overall goal is to develop a transformative community-driven intervention in partnership with a community partner to promote widespread access to rapid testing… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Health Behavior
- What is being tested?
- Supported Employment
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 102 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Aug 2023to 15 Mar 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18 and older
- Able to speak and understand English
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Supported Employment to Create a Community Culture of COVID-19 Rapid Testing Among People Who Inject Drugs: PeerConnect2Test
This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The overall goal is to develop a transformative community-driven intervention in partnership with a community partner to promote widespread access to rapid testing among PWID.
Read the detailed description
The program is called Peer Connect2Test (PeerC2T). PWID will be recruited by a community partner who provides syringe exchange services. The community partner will train PWID to become peer health workers (PHW) to distribute SARS-CoV-2 rapid tests to other PWID. Investigators expect that PeerC2T will improve knowledge, self-efficacy, and health behaviors among PHWs.
- Conditions
- Health Behavior
- Being tested
- Supported Employment
- Medical subject headings
- Health Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Supported EmploymentBehavioural
Also called Peer Connect2Test
PeerC2T is part of a supported employment program where PWID are trained and supported to provide PWID with job skills to be able to act as Peer Health Workers to facilitate the distribution of rapid SARS-CoV-2 testing to other PWID. The effect of the training on the Peer Health Worker themself will be evaluated.
| Study group | Role | What they receive |
|---|---|---|
| Supported Employment for Peer Health Workers | Experimental | Supported employment program (Peer Connect2Test) for people who inject drugs to provide SARS-CoV-2 rapid tests to others in their networks Receives: Behavioral: Supported Employment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant Peer Well-Being (Flourishing Scale)
Participant well-being was computed as the mean of eight items with a 7-point response option (1 = strongly disagree, 7 = strongly agree). The internal consistency, as measured with Cronbach's alpha (α), was .90, scores could range from 1 to 7, and higher scores indicated greater levels of well-being.
Measured: Assessed at baseline and 3-month follow-up
Secondary outcomes (10)
Health Communication Self-Efficacy
Health communication self-efficacy was computed as the mean score of 14 items with a 5-point response option (1 = strongly disagree, 5 = strongly agree). The internal consistency, as measured with Cronbach's alpha (α), was .97; scores could range from 1 to 5, and higher scores indicated greater self-efficacy.
Measured: Assessed at baseline and 3-month follow-up
Peer Support Self-Efficacy
Peer support self-efficacy, an Aim 1 measure, was computed as the mean score of 18 items with a 5-point response option (1 = not at all confident, 5 = very confident). The internal consistency, as measured with Cronbach's alpha (α), was .96; scores could range from 1 to 5, and higher scores indicated greater self-efficacy.
Measured: Assessed at baseline and 3-month follow-up
COVID-19 Knowledge
COVID-19 knowledge was computed as the number of correctly endorsed items. Five items were presented to test knowledge of COVID-19. Scores could range from 0 to 5, and higher scores indicate greater levels of COVID-19 knowledge.
Measured: Assessed at baseline and 3-month follow-up
HIV Knowledge
HIV knowledge was computed as the number of correctly endorsed items. Four items were presented to test understanding of HIV. Scores could range from 0 to 4, and higher scores indicate greater levels of HIV knowledge.
Measured: Assessed at baseline and 3-month follow-up
Hepatitis C Knowledge
Hepatitis C knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of hepatitis C knowledge.
Measured: Assessed at baseline and 3-month follow-up
Syphilis Knowledge
Syphilis knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of Syphilis knowledge.
Measured: Assessed at baseline and 3-month follow-up
Naloxone Knowledge
Naloxone knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of naloxone knowledge.
Measured: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times a Person Injected Drugs
Harm reduction risk behaviors included behaviors that occurred in the past month, and a higher score indicated greater levels of risky behavior. The injected drugs score was the total number of times a person reported they had injected drugs.
Measured: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times a Person Used Needles
Harm reduction risk behaviors included behaviors that occurred in the past month. The needle use score was a count of number of times they used a needle after someone else had used it (0 = none, 5 = more than 10 times), number of different people who used a needle before they had (0 = none, 5 = more than 10 times), number of times someone used a needle after they had (0 = none, 5 = more than 10 times), and before using needles how often they used bleach to clean the needles (0 = don't reuse, 5 = never). Scores could range from 0 to 20, and a higher score indicated a greater level of needle risky behaviors.
Measured: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times Person Engaged in Risky Intercourse Behaviors
Harm reduction risk behaviors included behaviors that occurred in the past month. The intercourse score was a count of the number of people a person had sex within the last month (0 = none, 5 = more than 10 people), the number of times a person used condoms when having sex with regular partner(s) in the last month (0 = no regular partner, 6 = never), how often they used condoms when they paid for sex (0 = not paid sex, 5 = never), how often they used condoms when having sex with casual partners (0 = no casual partners, 5 = never), and how many times they had anal sex in the last month (0 = 0 times, 5 = more than 5 times). Scores could range from 0 to 26, and a higher score indicated a greater level of intercourse risky behaviors.
Measured: Assessed at baseline and 3-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Aug 2023
- Study start3 Aug 2023
- Primary completion15 Mar 2025
- Study completion15 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Health BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 102 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Oregon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05984966
- Sponsor's protocol ID
- STUDY00000657
- Status last verified
- Apr 2025
- First submitted
- 28 Feb 2023
- Last updated
- 20 Apr 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: We have shared data with the RADx-UP Data Coordination Center at Duke University. Data was de-identified and is available to other researchers for further use.
Study at a glance
From the registry record, last updated by the sponsor on 20 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Supported Employment to Create a Community Culture of COVID-19 Rapid Testing Among People Who Inject Drugs: PeerConnect2Test
- ClinicalTrials.gov ID
- NCT05984966
- Acronym / sponsor ID
- STUDY00000657
- Conditions
- Health Behavior
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 102 participants (actual)
- Lead sponsor
- University of OregonUniversity, hospital or other
- Study start
- 3 Aug 2023 (actual)
- Primary completion
- 15 Mar 2025 (actual)
- Study completion
- 15 Mar 2025 (actual)
- First posted
- 9 Aug 2023 (actual)
- Results
- Posted 20 Apr 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The overall goal is to develop a transformative community-driven intervention in partnership with a community partner to promote widespread access to rapid testing among PWID.
Detailed description
The program is called Peer Connect2Test (PeerC2T). PWID will be recruited by a community partner who provides syringe exchange services. The community partner will train PWID to become peer health workers (PHW) to distribute SARS-CoV-2 rapid tests to other PWID. Investigators expect that PeerC2T will improve knowledge, self-efficacy, and health behaviors among PHWs.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Supported Employment for Peer Health Workers | Experimental | Behavioral: Supported EmploymentSupported employment program (Peer Connect2Test) for people who inject drugs to provide SARS-CoV-2 rapid tests to others in their networks |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age 18 and older
- Able to speak and understand English
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Supported EmploymentAlso: Peer Connect2TestPeerC2T is part of a supported employment program where PWID are trained and supported to provide PWID with job skills to be able to act as Peer Health Workers to facilitate the distribution of rapid SARS-CoV-2 testing to other PWID. The effect of the training on the Peer Health Worker themself will be evaluated. | Behavioural | Supported Employment for Peer Health Workers |
Primary outcome
Participant Peer Well-Being (Flourishing Scale)
Time frame: Assessed at baseline and 3-month follow-up
Participant well-being was computed as the mean of eight items with a 7-point response option (1 = strongly disagree, 7 = strongly agree). The internal consistency, as measured with Cronbach's alpha (α), was .90, scores could range from 1 to 7, and higher scores indicated greater levels of well-being.
10 secondary outcomes
Health Communication Self-Efficacy
Time frame: Assessed at baseline and 3-month follow-up
Peer Support Self-Efficacy
Time frame: Assessed at baseline and 3-month follow-up
COVID-19 Knowledge
Time frame: Assessed at baseline and 3-month follow-up
HIV Knowledge
Time frame: Assessed at baseline and 3-month follow-up
Hepatitis C Knowledge
Time frame: Assessed at baseline and 3-month follow-up
Syphilis Knowledge
Time frame: Assessed at baseline and 3-month follow-up
Naloxone Knowledge
Time frame: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times a Person Injected Drugs
Time frame: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times a Person Used Needles
Time frame: Assessed at baseline and 3-month follow-up
Harm Reduction Risk Behaviors - Number of Times Person Engaged in Risky Intercourse Behaviors
Time frame: Assessed at baseline and 3-month follow-up
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Apr 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: Yes. We have shared data with the RADx-UP Data Coordination Center at Duke University. Data was de-identified and is available to other researchers for further use.
Related trials for Health Behavior
Not yet recruiting
Effect of a Health Belief Model Based Digital Nudge Intervention on Breast Cancer Screening
Breast Cancer Screening, Breast Cancer Awareness
Not yet recruiting
The AYA Oncology Self-care Movement
Acute Lymphobkastic Leukemia, Medication Adherence
Not yet recruitingPhase 1
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
Well-Being, Psychological, Psychedelic Experiences
Not yet recruiting
Building Resilience Through Anxiety Virtual Education in PICU Survivors
Critical Illness Recovery, Mental Health
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Supported Employment in people with Health Behavior, run by University of Oregon at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 20 Apr 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant Peer Well-Being (Flourishing Scale) (time frame: Assessed at baseline and 3-month follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2026.